NCT04203446

Brief Summary

Asthma and COPD are common chronic diseases of respiratory system. The correct use of inhalers is crucial in terms of efficacy of the treatment, however both asthma and COPD patients quite frequently misuse the inhalers. The objective of this study is to determine the factors influencing the number of inhalation errors committed by asthma and COPD patients when using the inhalers. In included patients the inhalation technique will be evaluated (by both list of inhalation errors and 4 point scale of proper inhaling) by two observers and the below information will be collected:

  • general demographic information and education level
  • information concerning time of diagnosis, the previous course of disease, smoking history, number of previous inhalation techniques training, the sources of information about the inhalation technique and adherence to therapy
  • Asthma Control Test or COPD Assessment Test (respectively for asthma and COPD)
  • assessment of quality of life (St. George's Questionnaire for COPD and Asthma Quality of Life Questionnaire for asthma)
  • cognitive functions assessment using Mini-Mental State Examination
  • the simplified assessment of vision impairments
  • the results of spirometry

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 30, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 18, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2023

Completed
Last Updated

February 21, 2023

Status Verified

February 1, 2023

Enrollment Period

3.1 years

First QC Date

August 24, 2019

Last Update Submit

February 19, 2023

Conditions

Keywords

inhalation technique

Outcome Measures

Primary Outcomes (1)

  • Assessment of correctness of inhalation technique

    Assessment of correctness of inhalation technique by list of inhalation errors and 4 point scale of proper inhaling and by two observers

    baseline

Secondary Outcomes (11)

  • Assessment of general demographic features

    baseline

  • Assessment of educational level

    baseline

  • Assessment of general demographic features

    baseline

  • Assessment of asthma or COPD duration

    baseline

  • Assessment of asthma or COPD severity

    baseline

  • +6 more secondary outcomes

Study Arms (1)

Adults with asthma or COPD

Adults (18-85 years old) with asthma or COPD diagnosed at least 3 months earlier, who are regularly treated with at least one inhlaer daily

Other: Assessment of correctness of inhaling technique

Interventions

Assessment of correctness of inhaling technique in patients with asthma or COPD

Adults with asthma or COPD

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with asthma or COPD treated in hospital or in out-patient clinic will be asked for participating in the study

You may qualify if:

  • Informed consent for participating in the study
  • Age 18 -85 years
  • COPD or asthma diagnosed at least 3 months prior to enrolment
  • using of at least one inhaler regularly every day
  • using one of the inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI) or Metered Dose Liquid Inhalers (MDLI)

You may not qualify if:

  • Lack of informed consent
  • Age \<18 years or \> 85 years old
  • Diagnosis of asthma or COPD shorter than 3 months before enrollment
  • Using inhalers unregularly.
  • Symptoms of infection 5 days prior to beginning of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw

Warsaw, 02-097, Poland

Location

Related Publications (5)

  • Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H; European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011 Jun;37(6):1308-31. doi: 10.1183/09031936.00166410. Epub 2011 Feb 10.

  • Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M; Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011 Jun;105(6):930-8. doi: 10.1016/j.rmed.2011.01.005. Epub 2011 Mar 2.

  • Normansell R, Kew KM, Mathioudakis AG. Interventions to improve inhaler technique for people with asthma. Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD012286. doi: 10.1002/14651858.CD012286.pub2.

  • Sanchis J, Gich I, Pedersen S; Aerosol Drug Management Improvement Team (ADMIT). Systematic Review of Errors in Inhaler Use: Has Patient Technique Improved Over Time? Chest. 2016 Aug;150(2):394-406. doi: 10.1016/j.chest.2016.03.041. Epub 2016 Apr 7.

  • Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, Dekhuijzen R. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018 Jan 16;19(1):10. doi: 10.1186/s12931-017-0710-y.

MeSH Terms

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Rafał Krenke, MD,PhD,Prof

    Warsaw Medical Univeristy

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 24, 2019

First Posted

December 18, 2019

Study Start

October 30, 2019

Primary Completion

December 15, 2022

Study Completion

January 30, 2023

Last Updated

February 21, 2023

Record last verified: 2023-02

Locations